Restylane’s FDA Approval and Clinical Trials

Last updated: August 30, 2026

Restylane is a hyaluronic acid (HA) filler that has undergone extensive FDA oversight and clinical investigation, giving Portland-area patients strong, evidence-based reassurance as demand for non-surgical facial rejuvenation continues to grow. Unlike unregulated “beauty” products, every Restylane formulation has been studied in randomized controlled trials and approved through the FDA’s rigorous premarket approval pathway. That regulatory foundation translates into predictable, well-understood safety and efficacy profiles for patients weighing their options. Below is a complete guide to what Restylane’s FDA approval and clinical trials mean for anyone considering treatment.

What Is Restylane and How Does FDA Approval Work?

Restylane is a family of hyaluronic acid dermal fillers that work by replenishing HA naturally found in skin, restoring volume and smoothing lines wherever it is injected. HA is a water-binding molecule that gives skin its plump, hydrated quality, and Restylane’s crosslinked HA gel provides structure that integrates with facial tissue for natural-looking results.

What Makes Restylane Different From Other Dermal Fillers?

Restylane was the first HA filler approved for injection into facial tissue in the United States, earning its original FDA clearance in 2003 for correction of nasolabial folds. The product line has since expanded to address cheeks, temples, lips, the under-eye area, chin, and hands. Unlike temporary skin creams or unregulated “filler” products, Restylane is a prescription-strength medical device subject to the FDA’s highest review standard for injectable aesthetics. Each formulation in the Restylane family is manufactured under Good Manufacturing Practices, with rigorous quality control that ensures consistent particle size, gel hardness, and safety across every syringe.

How Does the FDA Approve a Dermal Filler Like Restylane?

The FDA requires injectable dermal fillers to complete premarket approval (PMA), a process that demands comprehensive clinical trial data demonstrating safety and effectiveness for a specific intended use. For a filler like Restylane, this means multi-center, randomized, controlled clinical trials with blinded evaluator assessments and long-term follow-up. The FDA reviews study protocols, adverse event reports, manufacturing data, and labeling before granting approval. This process means that when a patient receives an FDA-approved Restylane product, that specific formulation has demonstrated measurable results in rigorous, peer-reviewed clinical settings for that exact treatment area.

What Clinical Evidence Supports Restylane Safety?

Restylane’s FDA approval is backed by multiple high-quality randomized controlled trials that enrolled hundreds of patients and followed them for extended periods. These studies used standardized grading scales, blinded evaluators, and control groups to generate reliable, reproducible evidence about how well Restylane works and how long results last. The safety data collected across these trials consistently shows a reassuring profile for FDA-approved HA fillers when administered by qualified providers. Key findings from the landmark studies are summarized in the table below.

What Do the Major Restylane Trials Show?

The trial enrolled 140 subjects and demonstrated significantly greater Wrinkle Severity Rating Scale improvement over the comparator filler across the 15-month study period, with durable high aesthetic scores and a favorable safety profile. These data reflect the caliber of evidence supporting FDA-approved Restylane products.

How Long Did FDA-Studied Restylane Treatments Last?

Clinical trial data shows that Restylane’s effects are long-lasting but not permanent, which is consistent with HA’s biocompatible, biodegradable nature. In the infraorbital hollows trial, efficacy was sustained through Month 12 for 63.5% of treated patients and through Month 18 for 80.3% after one retreatment, whether delivered by needle or cannula. In the chin augmentation trial, effectiveness was sustained throughout 48 weeks with an 81% responder rate versus only 6% in the no-treatment control group. Individual results vary based on product formulation, treatment area, metabolism, and lifestyle factors, but the clinical evidence gives patients a realistic, evidence-based expectation for how long they can enjoy their results.

What Areas Can Restylane Treat on the Face?

Restylane’s FDA approval covers a wide range of facial treatment areas, making it one of the most versatile filler families available to patients today. From fine lip lines to deep nasolabial folds and from flat cheeks to sunken temples, each Restylane product is formulated for optimal performance in specific facial zones. The clinical trials that support its approvals were designed around these distinct treatment areas, meaning the safety and efficacy evidence is directly applicable to the concern a patient wants addressed.

Can Restylane Smooth Smile Lines and Marionette Lines?

Yes. Restylane’s original and most extensively studied indication is correction of nasolabial folds, commonly called smile lines or laugh lines, which run from the sides of the nose to the corners of the mouth. Marionette lines, which extend downward from the mouth corners toward the jawline, are also effectively treated with specific Restylane formulations. The landmark clinical trials demonstrated significant improvement in these areas using validated wrinkle severity scales, providing robust evidence that patients can expect meaningful, natural-looking smoothing of these common concerns.

Does Restylane Work for Cheek and Temple Volume Loss?

Absolutely. Loss of cheek volume and hollowing at the temples are hallmark signs of facial aging that Restylane addresses by rebuilding structural support beneath the skin. Portland patients concerned about flat cheeks, jowls, or a weakened chin profile can look to the chin augmentation trial data as a model of how well Restylane performs for structural facial enhancement. Temple hollows, often overlooked, also respond well to HA filler treatment for a refreshed, balanced appearance. Vip MediSpa offers cheek and chin augmentation to restore facial harmony, and practitioners can recommend the specific Restylane product best suited to each area’s unique anatomical needs.

What Should Portland Patients Expect From Restylane Treatment?

Restylane treatment at a qualified Portland-area practice is a straightforward, in-office procedure that requires no surgery and minimal downtime. Patients can expect a personalized approach where the provider evaluates facial anatomy, discusses aesthetic goals, and selects the optimal Restylane formulation and injection technique for the desired outcome. The entire process from consultation to completion is designed to be comfortable, efficient, and aligned with each patient’s individual timeline. Understanding what happens at each step helps Portland patients approach treatment with confidence.

How Does the Restylane Treatment Process Work?

A Restylane treatment begins with a one-on-one consultation where the provider assesses facial structure, skin quality, and the specific areas of concern. Treatment areas are cleansed and, in most cases, a topical or injectable numbing agent is applied for comfort. The HA gel is then carefully injected using precise placement techniques tailored to the treatment area and the desired result. The procedure typically takes 15 to 45 minutes depending on the number of areas treated, and patients can return to most normal activities immediately afterward.

What Is Restylane Recovery Like?

Restylane recovery is associated with minimal disruption to daily life. Common and temporary side effects include mild swelling, bruising, redness, or tenderness at the injection site, typically resolving within a few days. Most Portland patients find they can return to work or social activities within 24 to 48 hours. The provider will offer personalized aftercare instructions, which generally include avoiding strenuous exercise, excessive sun or heat exposure, and touching or massaging the treated area for a short period. Results are visible immediately after treatment, with final settling occurring over the following one to two weeks as the filler integrates with surrounding tissue.

Why Does FDA Approval Matter When Choosing a Dermal Filler?

FDA approval is more than a regulatory checkbox; it represents a documented commitment to patient safety and measurable clinical performance. Products that have completed the FDA’s rigorous approval pathway have been tested in controlled environments, evaluated by independent medical experts, and cleared for a specific, evidence-backed intended use. For patients navigating the growing range of injectable options, understanding what FDA approval means provides a meaningful framework for making confident, informed decisions about their care.

How Do FDA-Approved Fillers Compare to Unregulated Options?

FDA-approved fillers like Restylane have undergone the level of clinical scrutiny required for approval of a prescription medical device, meaning their safety and efficacy claims are substantiated by high-quality trial data reviewed by the FDA itself. Unregulated or black-market fillers carry unknown safety profiles, inconsistent formulations, and no guarantees about what patients are actually receiving. Choosing an FDA-approved product from a licensed, trained provider dramatically reduces the risk of adverse outcomes and ensures that the clinical evidence supporting that specific product is transparent and accessible.

What Questions Should You Ask About Filler Safety?

Patients should feel empowered to ask their provider directly about the FDA approval status of any filler they are considering, which specific Restylane formulation is recommended for their concern, and what clinical evidence supports that recommendation. Key questions include whether the product is FDA-approved for the planned treatment area, what the provider’s training and experience with that product includes, and what the safety and satisfaction data from clinical trials show. A qualified provider will welcome these questions and respond with specific, evidence-based answers. Vip MediSpa’s Restylane treatment page offers additional details on the science behind each formulation.

Where Can Portland Patients Get Restylane From Qualified Providers?

Vip MediSpa is a trusted destination for Restylane treatments in the Portland metropolitan area, offering FDA-approved fillers administered by experienced, licensed injectors who understand facial anatomy and aesthetic outcomes. The practice serves patients from Portland and surrounding communities including Lake Oswego, Beaverton, West Linn, Happy Valley, Milwaukie, King City, Tigard, Maywood Park, Durham, and Fairview, as well as patients traveling from Vancouver, Washington. Every Restylane treatment at Vip MediSpa is grounded in the same evidence-based approach that the FDA’s approval process demands: clinical precision, personalized planning, and a commitment to natural-looking results that align with each patient’s individual goals.

Frequently Asked Questions

What is Restylane and how does it work?

Restylane is a family of hyaluronic acid (HA) dermal fillers approved by the FDA for facial rejuvenation. The HA gel replenishes naturally occurring hyaluronic acid in the skin, restoring volume and smoothing lines. Its crosslinked structure integrates with facial tissue for natural-looking results. Restylane was the first HA filler approved for injection into facial tissue in the United States, receiving original FDA clearance in 2003.

How does the FDA approve dermal fillers like Restylane?

The FDA requires dermal fillers to complete premarket approval (PMA), demanding comprehensive clinical trial data demonstrating safety and effectiveness. This includes multi-center, randomized, controlled trials with blinded evaluator assessments and long-term follow-up. The FDA reviews study protocols, adverse event reports, manufacturing data, and labeling before granting approval for specific treatment areas.

How long do Restylane results last?

Restylane effects are long-lasting but not permanent, consistent with HA’s biocompatible nature. Clinical trials showed efficacy sustained through Month 12 for 63.5% of patients treated for infraorbital hollows, and through Month 18 for 80.3% after retreatment. Chin augmentation results maintained an 81% responder rate throughout 48 weeks. Individual results vary based on product formulation, treatment area, and metabolism.

What facial areas can Restylane treat?

Restylane holds FDA approval for treating multiple facial areas including nasolabial folds (smile lines), marionette lines, cheeks, temples, lips, under-eye hollows, chin, and hands. Each formulation is specifically designed for optimal performance in particular facial zones, with clinical trials supporting safety and efficacy for each distinct treatment area.

What should I expect during Restylane recovery?

Restylane recovery involves minimal disruption to daily life. Common temporary side effects include mild swelling, bruising, redness, or tenderness at injection sites, typically resolving within a few days. Most patients return to normal activities within 24 to 48 hours. Providers recommend avoiding strenuous exercise, excessive sun or heat exposure, and touching treated areas briefly after treatment.

Why is FDA approval important when choosing a dermal filler?

FDA approval represents documented commitment to patient safety and measurable clinical performance. Approved products like Restylane have been tested in controlled environments, evaluated by independent medical experts, and cleared for evidence-backed intended uses. Unregulated fillers carry unknown safety profiles and inconsistent formulations. FDA approval ensures clinical evidence is transparent, accessible, and reviewed by the FDA itself.

What does the Restylane treatment process involve?

A Restylane treatment begins with a consultation assessing facial structure, skin quality, and areas of concern. After cleansing and applying a numbing agent for comfort, the HA gel is carefully injected using precise placement techniques. The procedure typically takes 15 to 45 minutes depending on areas treated. Results are visible immediately, with final settling over one to two weeks as filler integrates with surrounding tissue.

Sources

• Efficacy and safety of a new resilient hyaluronic acid dermal filler, in the correction of moderate‐to‐severe nasolabial folds: A 64‐week, prospective, multicenter, controlled, randomized, double‐blind and within‐subject study
• A Multicenter, Randomized, Evaluator-Blinded Study to Examine the Safety and Effectiveness of Hyaluronic Acid Filler in the Correction of Infraorbital Hollows – PMC
• A Randomized Trial to Assess Effectiveness and Safety of a Hyaluronic Acid Filler for Chin Augmentation and Correction of Chin Retrusion – PMC